Contact UsCompany ProfileHome
Saaskin Technologies
Send Inquiry Send SMS    Call Me Free
Abbott BINAXNOW INFLUENZA A&B CARD

Abbott BINAXNOW INFLUENZA A&B CARD

Product Details:

  • Accuracy Influenza A Sensitivity: ~79.4%, Specificity: ~97.0%; Influenza B Sensitivity: ~79.5%, Specificity: ~97.6%
  • Function Detection of influenza A and/or B antigens from nasal or nasopharyngeal swab specimens
  • Display Type Visual (Result lines on card)
  • Usage Type Single Use
  • Instruments Type Rapid Diagnostic Test
  • Shelf Life 18 months from the date of manufacture
  • Measurement Range Qualitative assay (Positive/Negative)
  • Click to View more
X

Abbott BINAXNOW INFLUENZA A&B CARD Price And Quantity

  • 1 Unit

Abbott BINAXNOW INFLUENZA A&B CARD Product Specifications

  • Visual (Result lines on card)
  • Single Use
  • Detection of influenza A and/or B antigens from nasal or nasopharyngeal swab specimens
  • Influenza A Sensitivity: ~79.4%, Specificity: ~97.0%; Influenza B Sensitivity: ~79.5%, Specificity: ~97.6%
  • Rapid Diagnostic Test
  • 18 months from the date of manufacture
  • Yes
  • Qualitative Detection of Influenza A and B Viral Antigens
  • New
  • No
  • Other
  • Manual
  • Approx. 12 cm x 7 cm x 1 cm (per card)
  • Influenza A & B Rapid Test Card
  • Yes
  • Qualitative assay (Positive/Negative)
  • Store at 230C (3686F), protect from excessive moisture, do not freeze
  • Lateral Flow Immunoassay
  • Silent
  • Approx. 10 g (per card)
  • White with printed labeling
  • Easy to use, rapid results, point-of-care application, CLIA waived
  • Healthcare Professionals
  • English and local languages as per packaging region
  • Printed on each kit
  • Nasal or Nasopharyngeal Swab
  • Cassette/Card
  • Results in 15 minutes
  • BinaxNOW Influenza A & B Card
  • Visual interpretation
  • 25 test cards, 25 swabs, reagent, instructions for use
  • Biohazard waste according to local regulations

Product Description

Brand Abbott
Sample Type Fecal
Pack Size 20T
CAT No 44FK30

BinaxNOW Influenza A & B Card is an in vitro immunochromatographic assay for the qualitative detection of influenza A and B nucleoprotein antigens in nasopharyngeal (NP) swab, nasal swab samples and nasal wash/aspirate specimens. It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections.



Fast and Reliable Influenza Testing

The BinaxNOW Influenza A & B Card enables healthcare professionals to quickly detect influenza infections at the point of care. Visual results are available within 15 minutes, allowing for immediate clinical decisions and patient management. The simple design and easy-to-follow procedure reduce training needs while maintaining high specificity for accurate diagnosis.


Designed for Professional Use and Portability

Built for use by trained medical staff, this portable rapid test can be deployed in clinics, hospitals, and other healthcare settings. Its compact size, single-use format, and silent manual operation make it suitable for busy environments where swift and reliable test results are necessary for efficient patient care.

FAQ's of Abbott BINAXNOW INFLUENZA A&B CARD:


Q: How is the BinaxNOW Influenza A & B Card test performed?

A: To use the test, a healthcare professional collects a nasal or nasopharyngeal swab specimen from the patient, applies it to the test card with the provided reagent, and reads the result visually after 15 minutes following the instructions included in the kit.

Q: What types of samples are compatible with this influenza test?

A: The BinaxNOW Influenza A & B Card is designed to detect antigens from nasal or nasopharyngeal swab specimens, providing flexibility based on patient condition and clinical setting.

Q: When should the test be used during influenza season?

A: The test can be administered to patients presenting with symptoms suggestive of influenza, especially during peak flu season or outbreaks, to aid timely diagnosis and treatment decisions.

Q: Where can I use this rapid influenza test?

A: This test is intended for use by healthcare professionals in clinical environments such as hospitals, clinics, emergency rooms, and doctor's offices. It is not suitable for home use.

Q: What happens after obtaining a test result on the card?

A: Once the results are visually interpreted after 15 minutes, positive or negative outcomes help guide clinical management. Dispose of the used test cards, swabs, and reagents as biohazard waste according to local regulations.

Q: What benefits does this rapid test offer over laboratory-based assays?

A: The BinaxNOW test provides fast results at the point of care without the need for laboratory equipment, facilitating immediate decisions for patient isolation, antiviral therapy, or further testing within minutes.

Q: How should the test kits be stored and what is their shelf life?

A: Store the test kits at temperatures between 2-30C (36-86F), protected from excessive moisture and freezing. Each kit has a shelf life of 18 months from the manufacturing date, as indicated on the packaging.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Medical IVD' category



trade india member
SAASKIN CORPORATION PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.